CP Axtra PCL (BKK:CPAXT) Research & Development: ฿0 Mil (TTM As of Dec. 2025)


BKK:CPAXT CP Axtra PCL BKK:CPAXT
45 GF Score
Price ฿14.70
! 6 Warning Signs
View Full Analysis

What is CP Axtra PCL Research & Development?

CP Axtra PCL BKK:CPAXT 45 Research & Development is ฿0 Mil as of Dec. 2025. GuruFocus rates BKK:CPAXT with a GF Score™ of 45/100. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CP Axtra PCL's Research & Development for the three months ended in Dec. 2025 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was ฿0 Mil.

CP Axtra PCL  (BKK:CPAXT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CP Axtra PCL Research & Development Related Terms

CP Axtra PCL Research & Development Historical Data

* Premium members only.

The historical data trend for CP Axtra PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CP Axtra PCL Research & Development Chart

CP Axtra PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CP Axtra PCL Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:CPAXT
45GF Score
CP Axtra PCL BKK:CPAXT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CP Axtra PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0 Mil mean?
CP Axtra PCL (BKK:CPAXT) has a Research & Development of ฿0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CP Axtra PCL and its competitors.
Is CP Axtra PCL's Research & Development too high?
CP Axtra PCL's current Research & Development is ฿0 Mil. Overall, CP Axtra PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does CP Axtra PCL's Research & Development compare to SYY and USFD?
CP Axtra PCL's Research & Development of ฿0 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Defensive company?
A good Research & Development depends on the Retail - Defensive industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CP Axtra PCL and its competitors. CP Axtra PCL's current Research & Development is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CP Axtra PCL stock overvalued right now?
CP Axtra PCL (BKK:CPAXT) has a current Research & Development of ฿0 Mil. The current Research & Development is ฿0 Mil. CP Axtra PCL's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CP Axtra PCL (BKK:CPAXT), the current Research & Development is ฿0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CP Axtra PCL Business Description

Other Exchanges CPAXT-F:Thailand
Address 1468, Phattanakan Road, Phatthanakan, Khet Suan Luang, Bangkok, THA, 10250
CP Axtra PCL operates Makro brand stores and frozen food shops across Thailand. The company conducts its business through three segments: Wholesale, Retail, and Mall. Its operations consist of the sale of goods through wholesale, retail, and mall businesses, as well as the rendering of services related to those businesses. The majority of the company's revenue is generated from the Wholesale segment. The company operates in Thailand, Malaysia, and other markets, with the majority of its revenue coming from Thailand.
45GF Score

Get the complete analysis for BKK:CPAXT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿14.70
Price